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ABSTRACT  
The aim of this study was to prepare and evaluate microcapsules containing ibuprofen employing sodium alginate in combination with 
mucoadhesive  polymers  namely  methylcellulose,  Hydroxypropylmethylcellulose  and  sodiumcaboxymethylcellulose.  The  microcapsules 
were prepared by orifice-ionic gelation method. The microcapsules prepared are spherical, discrete, free flowing and were of multinucleate 
and monolithic type. Microencapsulation efficiency was in the range of 77.81-91.41 %. The in vitro drug release of the microcapsules carried 
out in phosphate buffer pH7.2 and drug release from the microcapsules was slow over 12 h and depends on core:coat ratio,  wall thickness 
and size of the microcapsules. The drug release from all the microcapsules  followed non-fickian diffusion. Microcapsules of alginate- 
methylcellulose gave relatively fast release when compared to others. The order of release rate observed with various microcapsules was 
sodiumcaboxymethylcellulose  <  Hydroxypropylmethylcellulose  <  methylcellulose.  Results  of  our  present  study  suggest  that  ibuprofen 
microcapsules  can  be  successfully  designed  to  develop  controlled  drug  delivery,  which  can  improve  compliance  by  reducing  dosing 
frequency. 
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INTRODUCTION 
Ibuprofen,  α-methyl-4-(2-methylpropyl)-benzene  acetic 
acid is a non-steroidal anti-inflammatory, antipyretic and 
analgesic drug. This drug is used for the relief of pain 
and  inflammation  in conditions such as dysmenorrhea, 
migraine, postoperative pain, dental pain. It is also used 
in  chronic  disorders  as  ankylosing  spondylitis, 
osteoarthritis and rheumatoid arthritis for all of which a 
sustained release is desirable
1. The usually oral dose of 
drug is 1.2 to 1.8 g divided in different administrations. 
The  drug  is  readily  absorbed  from  the  gastrointestinal 
tract, and peak plasma concentrations occur about 1 to 2 
h  after  ingestion
2-3.  Unfortunately,  ibuprofen  causes  a 
certain  irritation  in  the  gastrointestinal  mucous 
membrane and possesses a bitter taste and aftertaste. The 
half-life of the drug in plasma is about 2h. Due to short 
half life, drug is eliminated from body immediately. So 
ibuprofen  a  very  good  candidate  to  formulate  into 
controlled  release  formulations  to  maintains  the 
therapeutic concentration for prolonged period
4-6. At the 
same  time,  great  attention  has  been  devoted  on  the 
possibility to prepare ibuprofen microcapsules in order to 
formulate oral controlled release systems, to protect the 
gastric mucous membrane from drug irritation or to mask 
its unpleasant taste.  
Microcapsules  are  one  of  the  microparticulate  systems 
and are prepared to obtain prolonged or controlled drug 
delivery,  to  improve  bioavailability  or  stability  and  to 
target drug to specific sites. Microcapsules can also offer 
advantages  like  controlling  fluctuations  within 
therapeutic  range,  reducing  side  effects,  decreasing 
dosing  frequency  and  improving  patient  compliance. 
They  spread  out  more  uniformly  in  the  GI  tract,  thus 
avoiding exposure of the mucosa to high concentration 
of drug and ensuring more reproducible drug absorption. 
The risk of dose dumping also seems to be lower than 
with a single unit dosage form
7-9. In this study, ibuprofen 
microcapsules  were  prepared  by  a  novel  technique, 
called orifice-ionic gelation method.  
MATERIALS AND METHODS 
Ibuprofen was obtained as gift sample from M/s Micro 
Lab.  Ltd.,  Pondichery.  Methylcellulose  was  obtained 
from Qualigens, Mumbai (having a methoxyl content of 
28.32% by weight and viscosity of 65 cps in 0.5% w/v 
aqueous  solution  at  25ºC),  Hydroxylpropyl 
methylcellulose (HPMC), having a viscosity of 50 cps in 
a  2%  by  weight  aqueous  solution  at  20ºC),  Sodium 
carboxy  methylcellulose  (Sodium  CMC,  having  a 
viscosity of 1500 – 3000 cps in a 1% by weight aqueous 
solution  at  25ºC)  was  gift  samples  from  M/s  Natco Bantu Appa Rao et al. IRJP 2 (5) 2011 257-260 
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Pharma Ltd., Hyderabad. Sodium alginate was obtained 
from  SD  Fine  Chemicals,  Mumbai.  Calcium  chloride 
was  obtained  from  Qualigens,  Mumbai.  The  other 
chemicals  were  of  analytical  grade  and  distilled  water 
was used for all experiments. 
PREPARATION OF MICROCAPSULES  
Sodium alginate (1.0 g) and the mucoadhesive polymer 
(1.0 g) were dissolved in purified water (32 ml) to form a 
homogenous  polymer  solution.  The  core  material, 
ibuprofen  (1.0  g)  was  finely  powdered  and  passed 
through  mesh  No.  120  which  was  then  added  to  the 
polymer solution and mixed thoroughly to form a smooth 
viscous  dispersion.  The  resulting  dispersion  was  then 
added  drop  wise  into  calcium  chloride  (10%  w/v) 
solution (40 ml) through a syringe with a needle size No. 
16.  The  added  droplets  were  retained  in  the  calcium 
chloride  solution  for  15  min  to  complete  the  curing 
reaction  and  to  produce  spherical  rigid  microcapsules. 
The microcapsules were collected by decantation and the 
product thus separated was washed repeatedly with water 
and dried at 45ºC for 12 hrs. The microcapsules prepared 
along with their compositions are listed in Table.1. 
EVALUATION OF MICROCAPSULES 
The  microcapsules  prepared  were  evaluated  for  the 
following 
Drug content and microencapsulation efficiency 
Drug release kinetics 
Mechanism of drug release 
Drug content  
Ibuprofen content in the microcapsules was estimated by 
the  UV  spectrophotometrically  at  221nm.  From  each 
batch of microcapsules, 50 mg each of sample of were 
taken into 25 ml volumetric flasks and 10 ml methanol 
was added. The mixture was shaken thoroughly for about 
30 min while warming in a hot water bath to extract the 
ibuprofen from the microcapsules. The solution was then 
made  up  to  volume  with  methanol.  The  methanolic 
solution was subsequently diluted with phosphate buffer 
of pH 7.2 and determined for ibuprofen content.  
Microencapsulation Efficiency
10 
Microencapsulation efficiency was calculated using the 
formula, 
   
 
Drug Release study 
Release  of  ibuprofen  from  various  microcapsules  was 
studied  using  a  6-Station  Dissolution  Test  Apparatus 
(MDA-8/D, microprocessor Marrisons New Delhi, India) 
with a basket stirrer over a period of 12 hours. Phosphate 
buffer of pH7.2 (900ml) was used as dissolution fluid as 
prescribed  in  the  drug  release  test  for  ibuprofen.  A 
sample  of  microcapsules  equivalent  to  200  mg  of 
ibuprofen,  a  stirrer  with  speed  of  50  rpm  and  a 
temperature  of  37±0.5ºC  were  employed  in  each  test. 
Samples  (5ml)  of  dissolution  fluid  were  withdrawn 
through  a  filter  (0.45µ)  at  different  time  intervals  and 
were assayed at 221 nm for ibuprofen. At the end of the 
experiment the remaining microcapsules were collected 
and  the  amount  of  ibuprofen  remaining  in  the 
microcapsules were estimated and used in calculating the 
percent ibuprofen released at various times. Each drug 
test  is  repeated  three  (n=3)  times.  The  percent  of 
ibuprofen released at various times was calculated and 
plotted against time. The results are given in Fig.1.  
RESULTS AND DISCUSSION 
Microcapsules  of  ibuprofen  with  a  coat  consisting  of 
sodium  alginate  and  a  mucoadhesive  polymer  namely 
methyl cellulose, HPMC and sodium CMC in 1:1 and1:2 
ratios  could  be  prepared  by  the  orifice-ionic  gelation 
method.  Microcapsules  with  a  coat  of  mucoadhesive 
polymer  alone  could  not  be  prepared  because  of  their 
water soluble nature.  Low coefficient of variation values 
(<1.0%)  in  percentage  drug  content  indicated  that 
uniformity  of  drug  content  in  each  batch  of 
microcapsules. The microencapsulation efficiency was in 
the range of 77.81% - 91.41% shown in Table 2. The 
microcapsules were found to be discrete, spherical and 
free  flowing.  The  nature  of  the  method of  preparation 
indicated  that the  microcapsules  were  of  multinucleate 
and monolithic type. SEM photographs (Fig.2) indicated 
that  the  microcapsules  were  spherical  with  smooth 
surface and completely covered with the polymer coat.  
Ibuprofen release from the prepared microcapsules was 
studied in phosphate buffer P
H 7.2 (900 ml). The drug 
release  profiles  are  shown  in  Fig.1  and  drug  release 
parameters are summarized in Table.2. Ibuprofen release 
from all the coated microcapsules was slow and spread 
over a period of 12 h. Release data were analyzed as per 
zero order, first order, Higuchi, Peppas equation models 
to assess the drug release kinetics and mechanism from 
the microcapsules. The correlation coefficient (r
2) values 
in  the  analysis  of  release  data  as  per  different  kinetic 
models are given Table3. The analysis of release data as 
per  zero  and  first  order  kinetics  models  indicated  that 
ibuprofen release from the microcapsules followed zero 
order  kinetics.  Correlation  coefficient  (r
2)  values  were 
higher  in  the  zero  order  model  than  those  in  the  first 
order model with these microcapsules. When the release 
data  were  analyzed  as  per  the  Peppas  equation,  the 
release exponent (n) was in the range of 0.5425- 0.7716 Bantu Appa Rao et al. IRJP 2 (5) 2011 257-260 
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in  all  microcapsules  indicating  that  the  release 
mechanism  from  these  microcapsules  was  by  non- 
Fickian  diffusion.  Ibuprofen  release  from  the 
microcapsules  was  slow  and  dependent  on  the 
composition of the coat. Microcapsules of alginate- MC 
gave relatively fast release when compared to others. The 
order of release rate observed with various microcapsules 
was alginate-NaCMC < alginate-HPMC < alginate-MC. 
The  drug  released  from  microcapsules  was  diffusion 
controlled, as of amount released versus the square root 
of time were found to be linear (r
2 > 0.8906). Ibuprofen 
release  from  microcapsules  OMC6  was  slow  and 
extended  over  a  period  of  12  hours  and  these 
microcapsules  were  found  suitable  for  oral  controlled 
release formulation. 
CONCLUSION 
 It  may  be  concluded  that  Ibuprofen  microcapsules 
prepared using HPMC, MC and NaCMC as drug release 
modifiers  by  orifice  ionic  gelation  technique  is 
inexpensive,  free  from  any  organic  solvents  with  low 
manufacturing cost. The study also indicates that release 
of drug from the coated microcapsules obeyed diffusion 
controlled process and zero order release rate kinetics. 
Finally  from  the  study  it  may  be  concluded  that 
mucoadhesive microcapsules of ibuprofen is considered 
to  be    promising  pharmaceutical  dosage  forms  by 
providing controlled release drug delivery  systems and 
avoiding  the  dose  related  side  effects  in  the  entire 
physiological  region  and  may  improve  the 
bioavailability.  
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Table1: List of mucoadhessive microcapsules of ibuprofen 
 
S.No  Coat composition  Core: Coat  Code 
1  HPMC+Sodium alginate (1:1)  1:1  OMC 1 
2  MC + Sodium alginate (1:1)  1:1  OMC 2 
3  NaCMC + Sodium alginate 1:1)  1:1  OMC 3 
4  HPMC +Sodium alginate(1:1)  1:2  OMC 4 
5  MC+ Sodium alginate(1:1)  1:2  OMC 5 
6  NaCMC + Sodium alginate (1:1)  1:2  OMC 6 
 
HPMC- Hydroxy propyl methyl cellulose, MC-Methyl Cellulose, NaCMC-sodium caboxy methyl cellulose 
 
Table 2: Drug Content, Encapsulation Efficiency and Release Characteristics of mucoadhesive Microcapsules of Ibuprofen 
 
Micro- 
capsules 
Core: 
Coat 
Drug content 
(mean ±SD) 
Encapsulation 
efficiency 
K0 
(mg/ h) 
K1 
(h
-1) 
‘n’ in 
Peppas       
equation 
 
OMC1  1:1  43.73±0.256  81.21  13.052  0.198  0.6342 
OMC2  1:1  48.36±0.137  91.41  16.648  0.227  0.5425 
OMC3  1:1  50.00±0.101  85.21  10.185  0.148  0.7581 
OMC4  1:2  49.60±0.561  79.21  8.251  0.097  0.7516 
OMC5  1:2  49.59±0.266  77.81  9.362  0.115  0.6911 
OMC6  1:2  49.44±0.551  90.12  5.948  0.046  0.7716 
Values are given as mean ±SD of n=3 determinations 
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Table 3: Correlation Coefficient (r
2) Values of Mucoadhesive Microcapsules of   Ibuprofen as per Various Kinetic Models 
 
Microcapsules 
Correlation coefficient (r
2) values 
Zero order  first order  Higuchi  Peppas 
OMC 1  0.9652  0.8767  0.9863  0.988 
OMC 2  0.9501  0.8348  0.9545  0.9371 
OMC 3  0.9836  0.8651  0.9239  0.8975 
OMC 4  0.9814  0.8718  0.9271  0.969 
OMC 5  0.9614  0.7473  0.8963  0.9288 
OMC 6  0.9692  0.8452  0.8906  0.9775 
 
 
 
Fig 1: Drug release profiles of  mucoadhesive microcapsules of ibuprofen 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig 2: SEM photograph of mucoadhesive microcapsules of ibuprofen 
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